Systematic review / meta-analysis / 2024
Curcumin significantly reduced pain, total WOMAC scores, stiffness, and improved function in patients with osteoarthritis.
An umbrella meta-analysis was conducted across PubMed, Scopus, Embase, and Web of Science to examine the effects of curcumin supplementation on osteoarthritis outcomes up to September 2023. Based on 11 included meta-analyses of randomized controlled trials, curcumin significantly decreased VAS scores (both WMD and SMD p <= 0.001), WOMAC-total (SMD p <= 0.001, WMD p = 0.007), WOMAC-Function (SMD p <= 0.001, WMD p = 0.002), WOMAC-Pain (SMD p <= 0.001), and WOMAC-Stiffness scores (SMD p <= 0.001). The authors concluded that findings strongly support curcuminoid supplementation for pain relief, joint mobility, stiffness, and reduced medication usage in osteoarthritis patients.
- Study type
- Umbrella meta-analysis of randomized controlled trials
- Who was studied
- Osteoarthritis patients across 11 included meta-analyses
- What was measured
- VAS, WOMAC-total, WOMAC-Function, WOMAC-Pain, and WOMAC-Stiffness scores
THE PAPER
The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
Bideshki MV, Jourabchi-Ghadim N, Radkhah N, Behzadi M, Asemani S, Jamilian P, Zarezadeh M. Phytother Res, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.